 VANCOUVER, British Columbia, June 09, 2021 GLOBE NEWSWIRE -- InMed Pharmaceuticals Inc. InMed or the Company Nasdaq: INM, a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and leading the clinical development of cannabinol CBN, today announced that Eric. A. Adams, President and CEO of InMed, will present at 2021 BIO Digital, the premier biotech conference, which is being held virtually this year from June 10-11 and 14-18, 2021. 